中国卒中杂志2026，Vol.21Issue(1)：1-23,23.DOI:10.3969/j.issn.1673-5765.2026.01.001
卒中:回眸2025
Highlights in Stroke in 2025
熊云云 1沈柯佳 2唐奕哲 2王拥军 1路正钊 2马瑛 2单大卫 2吴娜 2郝曼均 2马宇洁 2武双喆 2李祉馨2
作者信息
- 1. 北京 100070 首都医科大学附属北京天坛医院神经病学中心||北京 100070 神经系统疾病国家临床医学研究中心||北京 102206 北京脑科学与类脑研究所
- 2. 北京 100070 首都医科大学附属北京天坛医院神经病学中心
- 折叠
摘要
Abstract
In 2025,clinical research in cerebrovascular diseases continued to advance amid challenges and opportunities.Global researchers conducted extensive explorations in expanding the boundaries of reperfusion therapy for ischemic stroke,optimizing adjuvant treatment strategies,and advancing precision in secondary prevention.Despite facing setbacks from negative outcomes in areas such as neuroprotection,endovascular treatment for medium vessel occlusion,and rehabilitation therapy,breakthrough progress in adjuvant reperfusion therapy and late-window thrombolysis injected strong momentum into clinical practice of cerebrovascular diseases.This article reviews and interprets key clinical studies in the field of cerebrovascular diseases in 2025,aiming to help readers grasp academic frontiers and track disciplinary developments through a synthesis of these high-quality studies,thereby enabling better alignment with evidence-based practices in clinical decision-making.关键词
脑血管病/缺血性卒中/再灌注治疗/二级预防/临床研究Key words
Cerebrovascular disease/Ischemic stroke/Reperfusion therapy/Secondary prevention/Clinical research分类
医药卫生引用本文复制引用
熊云云,沈柯佳,唐奕哲,王拥军,路正钊,马瑛,单大卫,吴娜,郝曼均,马宇洁,武双喆,李祉馨..卒中:回眸2025[J].中国卒中杂志,2026,21(1):1-23,23.
